EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS155-13373 
Organism
Homo sapiens 
Tissue/cell
Ovary 
Coordinate
chr8:28258360-28260460 
TF binding sites/motifs
Number: 40             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr8:28259755-28259773GGGAGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259854-28259872GGAGGGAGAGAAGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259874-28259892GGAGGGAGAGAAGGAGGG+6.03
EWSR1-FLI1MA0149.1chr8:28259332-28259350CCCTCCCTCCCTCCCTCC-6.03
EWSR1-FLI1MA0149.1chr8:28259862-28259880AGAAGGAGGGGAGGAGGG+6.2
EWSR1-FLI1MA0149.1chr8:28259842-28259860GGAGGGAGGGGAGGAGGG+6.34
EWSR1-FLI1MA0149.1chr8:28259815-28259833GGAAGGAAGGAAAGAGAG+7.37
KLF5MA0599.1chr8:28259467-28259477GCCCCGCCCC+6.02
KLF5MA0599.1chr8:28259529-28259539GCCCCGCCCC+6.02
KLF5MA0599.1chr8:28259940-28259950GGGGCGGGGC-6.02
ZNF263MA0528.1chr8:28259851-28259872GGAGGAGGGAGAGAAGGAGGG+10.09
ZNF263MA0528.1chr8:28259871-28259892GGAGGAGGGAGAGAAGGAGGG+10.09
ZNF263MA0528.1chr8:28259906-28259927AAAGCAGGGGAGGGGGAAGGG+6.09
ZNF263MA0528.1chr8:28259831-28259852AGTGGAGGGGCGGAGGGAGGG+6.15
ZNF263MA0528.1chr8:28259771-28259792GGGGGAGGGGTAGATGGGGAG+6.31
ZNF263MA0528.1chr8:28259785-28259806TGGGGAGGAGGGAGGGAGGAG+6.34
ZNF263MA0528.1chr8:28259716-28259737GGTGGAGAGAAGAGGGGAGGA+6.38
ZNF263MA0528.1chr8:28259836-28259857AGGGGCGGAGGGAGGGGAGGA+6.3
ZNF263MA0528.1chr8:28259742-28259763GAGGGAGGAGGTGGGGAGGAG+6.48
ZNF263MA0528.1chr8:28259802-28259823GGAGGAGGGACAGGGAAGGAA+6.56
ZNF263MA0528.1chr8:28259839-28259860GGCGGAGGGAGGGGAGGAGGG+6.59
ZNF263MA0528.1chr8:28259860-28259881AGAGAAGGAGGGGAGGAGGGA+6.5
ZNF263MA0528.1chr8:28259341-28259362CCTCCCTCCCGCCCCACCTCC-6.72
ZNF263MA0528.1chr8:28259764-28259785GAGGGAGGGGGGAGGGGTAGA+6.76
ZNF263MA0528.1chr8:28259734-28259755GGAGGAGGGAGGGAGGAGGTG+6.78
ZNF263MA0528.1chr8:28259753-28259774TGGGGAGGAGGGAGGGAGGGG+6.79
ZNF263MA0528.1chr8:28259738-28259759GAGGGAGGGAGGAGGTGGGGA+6.89
ZNF263MA0528.1chr8:28259911-28259932AGGGGAGGGGGAAGGGGAAAG+6.92
ZNF263MA0528.1chr8:28259843-28259864GAGGGAGGGGAGGAGGGAGAG+6.97
ZNF263MA0528.1chr8:28259748-28259769GGAGGTGGGGAGGAGGGAGGG+7.06
ZNF263MA0528.1chr8:28259728-28259749AGGGGAGGAGGAGGGAGGGAG+7.15
ZNF263MA0528.1chr8:28259745-28259766GGAGGAGGTGGGGAGGAGGGA+7.33
ZNF263MA0528.1chr8:28259760-28259781GAGGGAGGGAGGGGGGAGGGG+7.46
ZNF263MA0528.1chr8:28259848-28259869AGGGGAGGAGGGAGAGAAGGA+7.63
ZNF263MA0528.1chr8:28259868-28259889AGGGGAGGAGGGAGAGAAGGA+7.63
ZNF263MA0528.1chr8:28259863-28259884GAAGGAGGGGAGGAGGGAGAG+7.78
ZNF263MA0528.1chr8:28259788-28259809GGAGGAGGGAGGGAGGAGGAG+7.79
ZNF263MA0528.1chr8:28259799-28259820GGAGGAGGAGGGACAGGGAAG+7.98
ZNF263MA0528.1chr8:28259731-28259752GGAGGAGGAGGGAGGGAGGAG+8.28
ZNF263MA0528.1chr8:28259756-28259777GGAGGAGGGAGGGAGGGGGGA+9.49
Number of super-enhancer constituents: 27             
IDCoordinateTissue/cell
SE_00229chr8:28255250-28262078Adipose_Nuclei
SE_09976chr8:28255478-28260818CD14
SE_10881chr8:28255172-28272037CD20
SE_14002chr8:28257331-28258847CD34_Primary_RO01536
SE_14002chr8:28258909-28259726CD34_Primary_RO01536
SE_14002chr8:28259781-28261125CD34_Primary_RO01536
SE_17678chr8:28257238-28261225CD4p_CD25-_CD45RAp_Naive
SE_24655chr8:28258198-28260517Colon_Crypt_2
SE_26645chr8:28257250-28260912Esophagus
SE_27701chr8:28257858-28261004Fetal_Intestine
SE_28577chr8:28258026-28261038Fetal_Intestine_Large
SE_30513chr8:28257314-28261042Fetal_Muscle
SE_31606chr8:28257277-28260867Gastric
SE_36706chr8:28257941-28259351HMEC
SE_40988chr8:28257374-28260812Left_Ventricle
SE_42550chr8:28257572-28260838Lung
SE_48797chr8:28257261-28260697Right_Atrium
SE_50770chr8:28257241-28260963Sigmoid_Colon
SE_52497chr8:28257253-28260822Small_Intestine
SE_53710chr8:28257295-28261051Spleen
SE_55734chr8:28255502-28261747u87
SE_58644chr8:28219872-28277477Ly1
SE_59813chr8:28219869-28277603Ly4
SE_61002chr8:28174118-28277761HBL1
SE_61739chr8:28219999-28279573Toledo
SE_62508chr8:28220381-28270893Tonsil
SE_67509chr8:28255502-28261747u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr82825852828258941
chr82825991528260405
Enhancer Sequence
TGTGCGACCT CTGACAAACC GCTTTGCCTT TCTCAGCCTC CGTTCCTCAG GTGCAAAACG 60
GTTACCTGGG TGGTTATTAA GACATTACCA AGTTACGTGT CACAGCGTCT CTCTACTCTG 120
GATTTCTCAG ATAATGGAAA ACTGACTTCG TGGAGGAAGG CACCGCAACT GAGCCTGCTG 180
TCCTCAGTGT TCATGCAGAT ACCCTCGTGG AGCGCTCCAC GGTTTACGGA AAACTCTTGC 240
ATCGACTGCA TAAATTAGAA AATGAAGCGT AGGAGGCCAG ACTGCCTAGA GTACAGACTC 300
AGATCAGCTT AGTGCGTGAC TGGAGTCTCA TGCAGGCACA CAAACCATAG GGCGATGCTG 360
CCACCGAGTC ATTTCCTGGA TTAGGAGAAG TGGCAGAGAC GCCCTCAGGG ACCACACGTG 420
TCAGATCTCC ACCTCCCAAG CAGCGTTGCC CGGACGCGCC GCTCGGGGCC CAGAGCGCTG 480
CGTGCACGCA GCCTCTAGCA ACCACTTACC GCGTGTGTGC GCATGTGTGT ACGTGTGTGT 540
GCACGTGTGT ATATGTGTAG GTGCACGCAG GCGTGTGCGC GAGTGTGTGT ACGTGTGTGT 600
ACACGCGTGT ATATGTGTGG GTGCGCGAGT GTGTATGTGT GTGACGCGTG TGTACGTGTG 660
TATGCGCACG TGTGAGTGCA CTCGGGTGTA TGTGCTTGTG TGCACGCGCG CGTGTGTATC 720
CGTGTGTGTG CGCGTGTATT TGTGCATGTG TGAGCGCGCC CGTGTGTGCA CGCATGTGTG 780
TACGTATGTG TGTCGTGTGT GCGCGCGTGT ATGTGCGTGT GTGCGCACTC GGGGGTGTAC 840
GTGTGAGTGC GCGCGCGCAC GCGTGTCTGT GTGTGTGGCA TGGGAGGTGG GCGGCAAGGA 900
AAGCAGGCGA GACATTTTTT AAATAAAATA AGAAAAATAA AAGCCCAGCC TTCCAGGGCG 960
TCTTCAGCCA GCCCCTCCCT CCCTCCCTCC CGCCCCACCT CCGGCTCCGG GGCCGCGGCT 1020
CCGGCGCCGC GTTTTCCCGG CCGCCCCGCG CCCGAGGGTT AAAGCTCCCC CGCCAGGAGT 1080
AAACAGCACC CCAGTCGGCA GCCGGCAGCC CCGCCCCTCG GCCCGTTTCC TGCGCCAGCC 1140
CTGGCAACAG GCCCCGCCCT TCGCGACAAG CCCCGCCCCG CGCCATCCGT CTGGCCCTTC 1200
CTGGCGTCCG CCTACTAGCG GCGGGGTCCC GGCCCGTGCC GAGTGCCCAG CCAGCCCCAA 1260
CCCTCTTCCC CCGGGATTCT GCGGCCAGAG CCCCAGCCGA GGGAGGGTGC GTGCCGCGCA 1320
CGTGACTCTT GTTGTAGGCG GGGCCTGCGC AGCGTCGGTG GAGAGAAGAG GGGAGGAGGA 1380
GGGAGGGAGG AGGTGGGGAG GAGGGAGGGA GGGGGGAGGG GTAGATGGGG AGGAGGGAGG 1440
GAGGAGGAGG GACAGGGAAG GAAGGAAAGA GAGTGGAGGG GCGGAGGGAG GGGAGGAGGG 1500
AGAGAAGGAG GGGAGGAGGG AGAGAAGGAG GGGAGGGACG GAGGGGAAAG CAGGGGAGGG 1560
GGAAGGGGAA AGCAGGGGAA GGGGCGGGGC GAGGGTCTGG CCTAGTCTCC TCCAGCTTCG 1620
TGGAGCCCGC CTGGGGCGCC GCTCTCCCGC CCCCGCCCCT CCACGGGTCC AGCTGGGAAC 1680
TGGCTATGGC CTCGCCGCCC GGCGAGGGCT GCAGTGGGTT CCCCGACGAC TTTGCCGCGG 1740
TTGCTGCTTC TGCCAGCGCA GCCTCGGAGC GCTGCCCGGC TGCAGGGCTC TCACCTCTTC 1800
CCCAGGTCCC TGCTCAGCAG AGCCTCTTAA GCTTCCTGCC TGTGTCCACA GAACCCGACA 1860
TCTCAAGCCC CCTGAACGCA CAGGCTCCTG CTGCATAAAC ACCCCGCCCT CCTGCCTCCT 1920
GCACACACAG GCCTACATTG TAGGGCCTCC CACGCCTCTC CGTTCCTGGA ATGGAGCTCA 1980
CCTAACCCTG TGCTCGTCCT GCTGTCTTCT CTAAGGGTGG GGAAACTTGA GGTTCAGAAA 2040
GCTGGAAGGA TTTCAGTGTG CACCATACAT CGACCACACA ACAGTCCCAC TCCTAGGTAT 2100